Aim Immunotech INC. (AIM) — S-1 Filings

S-1 Filings (5)

• AIM ImmunoTech Launches Rights Offering Amidst Promising Cancer, Antiviral Trials — Dec 12, 2025 Risk: high
  AIM ImmunoTech Inc. (AIM) is conducting a Rights Offering to purchase up to 12,000 Units, each consisting of one share of Series G Convertible Preferred Stock a
• AIM ImmunoTech Files S-1 for Public Offering — Jan 23, 2025 Risk: medium
  AIM ImmunoTech Inc. filed an S-1 form on January 23, 2025, indicating a public offering of its securities. The company, previously known as Hemispherx Biopharma
• AIM ImmunoTech Files S-1 for Public Offering — Nov 15, 2024 Risk: medium
  AIM ImmunoTech Inc. filed an S-1 registration statement with the SEC on November 15, 2024, to register securities for public sale. The company, formerly known a
• AIM ImmunoTech Files S-1 for Public Offering — Jul 11, 2024 Risk: medium
  AIM ImmunoTech Inc. filed an S-1 registration statement on July 11, 2024, to potentially offer securities to the public. The company, formerly known as Hemisphe
• AIM ImmunoTech Inc. Files S-1 Registration Statement — Apr 19, 2024 Risk: low
  AIM ImmunoTech Inc. (AIM) filed a IPO Registration (S-1) with the SEC on April 19, 2024. AIM ImmunoTech Inc. filed an S-1 registration statement with the SEC on

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX